Tramadol Hydrochloride
Product Images NDC 53002-4320

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 53002-4320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530024320)

FDA Label Image

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)

FDA Label Image

Figure 1 (Tramadol HCl Tablets Usp 2)

FDA Label Image

Fig 2 (Tramadol HCl Tablets Usp 3)

Fig 2 (Tramadol HCl Tablets Usp 3)
This appears to be a figure from a study labeled "Protocol CAPSS-047" showing the percentage of participants who discontinued the study due to nausea/vomiting over a range of days in a double-blind period. The graph shows that there was a gradual increase in discontinuation with time, from 10% at 5 days to 50% at 20 days.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.